Coenzyme Q10 in cardiovascular and metabolic diseases. - GreenMedInfo Summary
Coenzyme Q10 in Cardiovascular and Metabolic Diseases: Current State of the Problem.
Curr Cardiol Rev. 2018 ;14(3):164-174. PMID: 29663894
Vladlena I Zozina
The burden of cardiovascular and metabolic diseases is increasing with every year. Although the management of these conditions has improved greatly over the years, it is still far from perfect. With all of this in mind, there is a need for new methods of prophylaxis and treatment. Coenzyme Q10 (CoQ10) is an essential compound of the human body. There is growing evidence that CoQ10 is tightly linked to cardiometabolic disorders. Its supplementation can be useful in a variety of chronic and acute disorders. This review analyses the role of CoQ10 in hypertension, ischemic heart disease, myocardial infarction, heart failure, viral myocarditis, cardiomyopathies, cardiac toxicity, dyslipidemia, obesity, type 2 diabetes mellitus, metabolic syndrome, cardiac procedures and resuscitation.